SphK1 Activators
Common SphK1 Activators include, but are not limited to Cholecalciferol CAS 67-97-0, Dimethyloxaloylglycine (DMOG) CAS 89464-63-1, Lysophosphatidic Acid CAS 325465-93-8, Forskolin CAS 66575-29-9 and PMA CAS 16561-29-8.
Sphingosine kinase 1 (SphK1) activators belong to a class of chemical compounds that exert their influence on a specific enzyme known as sphingosine kinase 1. SphK1 is a critical enzyme involved in the regulation of sphingolipid metabolism, specifically in the conversion of sphingosine into sphingosine-1-phosphate (S1P). Sphingolipids are essential components of cell membranes and play pivotal roles in various cellular processes, including cell growth, survival, and signal transduction. Consequently, modulating the activity of SphK1 through the use of activators can have profound effects on cell behavior and function.
SphK1 activators typically work by enhancing the catalytic activity of SphK1, leading to an increased production of S1P. This elevation of S1P levels can trigger a cascade of intracellular signaling events, as S1P serves as a bioactive lipid mediator involved in multiple cellular responses. These activators can be small molecules or compounds designed to interact with the enzyme, promoting its enzymatic activity. Understanding and developing SphK1 activators are of particular interest in the field of molecular biology and cell signaling research, as they offer insights into the intricate mechanisms governing cell behavior and can be harnessed for various applications, including the study of cellular communication, signal transduction pathways, and the exploration of expression pathways regulating cell responses.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Vitamin D3 may regulate SphK1 expression, potentially through vitamin D receptor (VDR) activation. VDR can act as a transcription factor, influencing SphK1 gene transcription. This modulation of SphK1 expression indirectly impacts sphingolipid metabolism, affecting the conversion of sphingosine to sphingosine-1-phosphate (S1P). | ||||||
Dimethyloxaloylglycine (DMOG) | 89464-63-1 | sc-200755 sc-200755A sc-200755B sc-200755C | 10 mg 50 mg 100 mg 500 mg | $84.00 $301.00 $374.00 $779.00 | 25 | |
Stabilization of hypoxia-inducible factor 1-alpha (HIF-1α) can induce SphK1 expression. HIF-1α is a transcription factor regulating genes in response to hypoxia, including SphK1. This modulation of SphK1 expression indirectly influences sphingolipid metabolism, affecting the conversion of sphingosine to sphingosine-1-phosphate (S1P). | ||||||
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $98.00 $341.00 | 50 | |
Lysophosphatidic acid (LPA) binds to LPA receptors (G protein-coupled receptors), triggering intracellular signaling cascades that upregulate SphK1 expression. This modulation of SphK1 expression indirectly influences sphingolipid metabolism, affecting the conversion of sphingosine to sphingosine-1-phosphate (S1P). | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin elevates intracellular cAMP levels, which, in turn, activate protein kinase A (PKA). PKA can influence SphK1 expression through downstream signaling pathways involving transcription factors. This modulation of SphK1 expression indirectly impacts sphingolipid metabolism, affecting the conversion of sphingosine to sphingosine-1-phosphate (S1P). | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate activates protein kinase C (PKC), leading to the subsequent upregulation of SphK1 expression. This modulation of SphK1 expression indirectly impacts sphingolipid metabolism, affecting the conversion of sphingosine to sphingosine-1-phosphate (S1P). | ||||||
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $98.00 $171.00 $425.00 $1560.00 | 12 | |
Lipopolysaccharide (LPS) activates SphK1 expression through the Toll-Like Receptor 4 (TLR4)/NF-κB signaling pathway. LPS binding to TLR4 initiates a signaling cascade that results in the activation of NF-κB and subsequent SphK1 induction. This modulation of SphK1 expression indirectly influences sphingolipid metabolism, impacting the conversion of sphingosine to S1P. | ||||||
C2 Ceramide | 3102-57-6 | sc-201375 sc-201375A | 5 mg 25 mg | $124.00 $460.00 | 12 | |
C2-ceramide is a cell-permeable ceramide analog that can activate SphK1 directly or indirectly through its impact on ceramide metabolism and signaling pathways. This compound directly influences SphK1 activity and, consequently, sphingolipid metabolism, affecting the conversion of sphingosine to sphingosine-1-phosphate (S1P). | ||||||